To further elaborate on DLBCL dissemination, we also exploited in vivo studies to thoroughly delineate the impacts of PI3K inhibition on tumor spreading (Figure 6b–e). The gene discussed is PIK3CD; the disease is diffuse large B-cell lymphoma.